Golden Biotechnology Corporation (4132.TWO)
TWD 15.0
(-0.33%)
TWD 15.0
(-0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 63.42 Million | 217.82 Million | 81.76 Million | 88.82 Million | 83.29 Million |
| Cost of Revenue | 47.37 Million | 66.03 Million | 69.08 Million | 64.16 Million | 38.42 Million |
| Gross Profit | 16.05 Million | 151.79 Million | 12.68 Million | 24.65 Million | 44.86 Million |
| Operating Expenses | 381.63 Million | 448.56 Million | 436.53 Million | 372.69 Million | 325.8 Million |
| Selling, General and Administrative Expenses | 179.11 Million | 170.14 Million | 171.43 Million | 177.92 Million | 173.2 Million |
| Research and Development Expenses | 202.52 Million | 278.42 Million | 265.09 Million | 194.77 Million | 142.11 Million |
| Other Expenses | - | 24.75 Million | -14.32 Million | -37.02 Million | - |
| Cost and Expenses | 429.01 Million | 514.59 Million | 505.61 Million | 436.86 Million | 364.23 Million |
| Operating Income | -365.58 Million | -267.68 Million | -437.84 Million | -384.78 Million | -270.45 Million |
| Interest Expense | 6.73 Million | 4.07 Million | 3.69 Million | 4.14 Million | 4.24 Million |
| Income Tax Expense | 293 Thousand | 116 Thousand | 2.3 Million | 2.55 Million | 157 Thousand |
| Earnings before Tax | -361.34 Million | -271.76 Million | -441.53 Million | -388.82 Million | -284.96 Million |
| Net Income | -361.64 Million | -271.87 Million | -443.83 Million | -391.37 Million | -285.12 Million |
| Earnings Per Share Basic | -2.39 | -1.91 | -3.36 | -3.49 | -2.43 |
| Earnings Per Share Diluted | -2.54 | -1.91 | -3.36 | -3.11 | -2.48 |
| Weighted Average Shares Outstanding | 151.38 Million | 142.22 Million | 132.22 Million | 112.23 Million | 117.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 142.37 Million | 142.22 Million | 132.22 Million | 125.68 Million | 114.97 Million |
| Gross Margin | 0.25 | 0.70 | 0.16 | 0.28 | 0.54 |
| EBIT Margin | -4.79 | -0.99 | -4.73 | -3.69 | -2.69 |
| Profit Margin | -5.70 | -1.25 | -5.43 | -4.41 | -3.42 |
| EBITDA | -303.59 Million | -216.48 Million | -386.65 Million | -327.76 Million | -214.72 Million |
| Earnings Before Tax Margin | -5.76 | -1.23 | -5.35 | -4.33 | -3.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 11.47 Million | 11.47 Million | 17.26 Million | 63.42 Million | 17.26 Million | 14.44 Million |
| Cost of Revenue | 10.2 Million | 10.2 Million | 17.49 Million | 47.37 Million | 17.49 Million | 6.19 Million |
| Gross Profit | 1.27 Million | 1.27 Million | -221.5 Thousand | 16.05 Million | -221.5 Thousand | 8.24 Million |
| Operating Expenses | 81.79 Million | 80.63 Million | 109.48 Million | 381.63 Million | 109.48 Million | 80.25 Million |
| Selling, General and Administrative Expenses | 42.71 Million | 42.71 Million | 43.08 Million | - | 43.08 Million | 46.47 Million |
| Research and Development Expenses | 39.07 Million | 39.07 Million | 64.28 Million | - | 64.28 Million | 36.97 Million |
| Other Expenses | - | - | - | 2.15 Million | - | - |
| Cost and Expenses | 92 Million | 90.84 Million | 126.97 Million | 429.01 Million | 126.97 Million | 86.45 Million |
| Operating Income | -80.52 Million | -80.52 Million | -107.58 Million | -354.61 Million | -107.58 Million | -75.2 Million |
| Interest Expense | - | - | - | 6.73 Million | - | - |
| Income Tax Expense | - | - | 146.5 Thousand | 293 Thousand | 146.5 Thousand | - |
| Earnings before Tax | -80.39 Million | -80.39 Million | -109.11 Million | -361.34 Million | -109.11 Million | -71.56 Million |
| Net Income | -80.39 Million | -80.39 Million | -109.25 Million | -361.64 Million | -109.25 Million | -71.56 Million |
| Earnings Per Share Basic | -0.57 | -0.57 | -0.77 | - | -0.77 | -0.50 |
| Earnings Per Share Diluted | -0.57 | -0.57 | -0.77 | - | -0.77 | -0.50 |
| Weighted Average Shares Outstanding | 142.22 Million | 142.29 Million | 142.22 Million | 142.37 Million | 142.22 Million | 142.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 142.22 Million | 142.29 Million | 142.22 Million | 142.37 Million | 142.22 Million | 142.22 Million |
| Gross Margin | 0.11 | 0.11 | -0.01 | 0.25 | -0.01 | 0.57 |
| EBIT Margin | -6.38 | -5.99 | -5.98 | - | -5.98 | -4.32 |
| Profit Margin | -7.01 | -7.01 | -6.33 | -5.70 | -6.33 | -4.95 |
| EBITDA | -73.27 Million | -68.71 Million | -103.27 Million | - | -103.27 Million | -62.44 Million |
| Earnings Before Tax Margin | -7.02 | -7.02 | -6.23 | -5.59 | -6.23 | -5.21 |
ATLPF
100120
IPIC
PINF
NYMXF
003030